Peter Mulligan

Peter Mulligan is a collaborative and versatile life scientist currently serving as a Group Leader at INSERM and the Institut NeuroMyoGène in Lyon, France. With extensive expertise in cancer research and epigenetics, they have a proven track record in target discovery and validation, employing advanced techniques such as NGS and proteomics. Prior to their current role, Peter completed postdoctoral fellowships at Harvard Medical School and Massachusetts General Hospital, and led a team at the Cancer Research Centre of Lyon from 2013 to 2021. Peter holds a Ph.D. in Cellular and Molecular Biology from the University of London, and a B.Sc. in Biotechnology from the National University of Ireland, Galway.